513
Views
27
CrossRef citations to date
0
Altmetric
Articles

Role of GSK-3β in Regulation of Canonical Wnt/β-catenin Signaling and PI3-K/Akt Oncogenic Pathway in Colon Cancer

, , &
Pages 473-483 | Received 21 Sep 2016, Accepted 08 May 2017, Published online: 18 Jul 2017

References

  • Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 1999;18:5931–5942.
  • Hardt SE, Sadoshima J. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res 2002;90:1055–1063.
  • Hoffmans R, Stadeli R, Basler K. Pygopus and legless provide essential transcriptional co-activator functions to armadillo/beta-catenin. Curr Biol 2005;15:1207–1211.
  • Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of apchetero zygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 1995;92:4482–4486.
  • Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009;9:550–562.
  • Caro AA, Cederbaum AI. Role of phosphatidylinositol 3-kinase/Akt as a survival pathway against CYP2E1-dependent toxicity. J Pharmacol Exp Ther 2006;318:360–372.
  • Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2002;2:489–501.
  • Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 2003;22:8983–8998.
  • Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009;4:127–150.
  • Parsons R. Human cancer, PTEN and the PI-3 kinase pathway. Semin Cell Dev Biol 2004;15:171–176.
  • Kaler P, Godasi BN, Augenlicht L, Klampfer L. The NF-kappaB/AKT-dependent induction of Wnt signalling in colon cancer cells by macrophages and IL-1 beta. Cancer Microenviron 2009;2:69–80.
  • Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin 2010;26(7):1715–1731.
  • Vankatesan P, Puvvada N, Dash R, Prashanthkumar BN, Sarkar D, Azab B, et al. The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer. Biomaterials 2011;32(11):3794–3806.
  • Sanyal SN, Jain S, Ghanghas P, Rana C. Activation of mitochondrial apoptosis and regulation of ceramidesignalling by COX-2 inhibitors in colon cancer. Translational Med 2015;5(159):2161–2167. doi:10.4172/2161-1025.1000159
  • Ghanghas P, Jain S, Rana C, Sanyal SN. Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancer. Biomed Pharmacother 2016;78:239–247.
  • Vaish V, Piplani H, Rana C, Sanyal SN. Angiostatic properties of sulindac and celecoxib in the experimentally induced inflammatory colorectal cancer. Cell Biochem Biophys 2013;66:205–227.
  • Rana C, Piplani H, Vaish V, Nehru B, Sanyal SN. Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by diclofenac and curcumin in colon cancer. Mol Cell Biochem 2015;402:225–224.
  • Rana C, Vaish V, Piplani H, Nehru B, Sanyal SN. Nuclear factor-κB is expressed in early colon cancer and its downregulation by curcumin and diclofenac is associated with the suppression of proliferation and the induction of apoptosis. Biomed Prev Nutr 2012;2:228–238.
  • Mouillé B, Robert V, Blachier F. Adaptative increase of ornithine production and decrease of ammonia metabolism in rat colonocytes after hyperproteic diet ingestion. Am J Physiol Gastrointest Liver Physiol 2004;287:G344–G351.
  • Rana C, Piplani H, Vaish V, Nehru B, Sanyal SN. Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer. Tumour Biol 2015;36(8):5999–6010. doi:10.1007/s13277-015-3276-7
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 1976;72:248–254.
  • Kanayama M, Takahara T, Yata Y, Xue F, ShinnoE. Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signalling. Am J Physiol Gastrointest Liver Physiol 2007;293:G230–G239.
  • Yuan YJ, Ge ZQ, Li JC, Hu ZD. Differentiation of apoptotic and necrotic cells in suspension cultures of Taxuscuspidata by the combined use of fluorescent dying and histochemical staining methods. Biotechnol Lett 2002;24:71–76.
  • Gwyn K, Sinicrope FA. Chemoprevention of colorectal cancer. Am J Gastroenterol 2002;97:13–21.
  • Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al. The effect of ncelecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946–1952.
  • Hallak A, Alon-Baron L, Shamir R, Moshkowitz M, Bulvik B, Brazowski E, et al. Rofecoxib reduces polyp recurrence in familial polyposis. Dig Dis Sci 2003;48:19988–12002.
  • Rao CV, Indranie C, Simi B, Mannig PT, Connor JR, Reddy BS. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 2002;62:165–170.
  • Dashwood RH, Xu M, Orner GA, Horio DT. Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2-amino-3-methylimidaz. Eur J Cancer Prev 2001;10(2):139–145.
  • McLellan EA, Medline A, Bird RP. Dose response and proliferation characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis 1991;12(11):2093–2098.
  • Ramaswamy S, Nakamura N, Bazquez F, Batt BB, Perera S, Roberts TM, et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1999;96:2110–2115.
  • Kandel ES, Skeen J, Majewski N, Di-Cristofano A, Pandolfi PP, Feliciano CS, et al. Activation of Aoikt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol 2002;22:7831–7841.
  • Testa JR, Bellacosa A. Akt plays a central role in tumorigenesis. Proc Natl Acad Sci USA 2001;98:10983–10985.
  • Jiang BH, Liu LZ. PI3K/PTEN signalling in tumorigenesis and angiogenesis. Biochim Biophys Acta 2008;1784:150–158.
  • Sheng H, Shao J, Townsend CMJ, Evers BM. Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells. Gut 2003;52:1472–1478.
  • Tanaka T, Suzuki R, Kohno H, Sugie S, Takahashi M, Wakabayashi K. Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase. Carcinogenesis 2005;26:229–238.
  • Cohen P, Frame S. The renaissance of GSK-3. Nat Rev Mol Cell Biol 2001;2:769–776.
  • Giles RH, Van EJH, Clevers H. Caught up in a Wnt storm: Wnt signalling in cancer. Biochem Biophys Acta 2003;1653:1–24.
  • Korinek V, Barker N, Morin PJ, Wichen DV, Weger RD, Kinzler KW, et al. Constitutive transcriptional activation by a β-Catenin-Tcf complex in APC−/− colon carcinoma. Science 1997;275:1784–1787.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.